Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial-Reference-Cited by-同舟云学术

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

Published:2019-08 Issue:10196 Volume:394 Page:385-395
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Widmark Anders,Gunnlaugsson Adalsteinn,Beckman Lars,Thellenberg-Karlsson Camilla,Hoyer Morten,Lagerlund Magnus,Kindblom Jon,Ginman Claes,Johansson Bengt,Björnlinger Kirsten,Seke Mihajl,Agrup Måns,Fransson Per,Tavelin Björn,Norman David,Zackrisson Björn,Anderson Harald,Kjellén Elisabeth,Franzén Lars,Nilsson Per

Publisher

Elsevier BV

Subject

General Medicine

Reference26 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018

2. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018;Ferlay;Eur J Cancer,2018

3. Fractionation and late rectal toxicity;Brenner;Int J Radiat Oncol Biol Phys,2004

4. Prostate alpha/beta revisited—an analysis of clinical results from 14 168 patients;Dasu;Acta Oncol,2012

5. Dose response and fractionation sensitivity of prostate cancer after external beam radiation therapy: a meta-analysis of randomized trials;Vogelius;Int J Radiat Oncol Biol Phys,2018

Cited by 597 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elective pelvic nodal irradiation in the setting of ultrahypofractionated versus moderately hypofractionated and conventionally fractionated radiotherapy for prostate cancer: Outcomes from 3 prospective clinical trials;Clinical and Translational Radiation Oncology;2024-11

2. Single–dose high-dose-rate brachytherapy versus two and three fractions for locally advanced prostate cancer;Radiotherapy and Oncology;2024-10

3. Preoperative Ultrahypofractionated Radiation Therapy for Soft Tissue Sarcomas: Low Rate of Wound Complications;Advances in Radiation Oncology;2024-10

4. Genetic markers of late radiation toxicity in the era of image-guided radiotherapy: lower toxicity rates reduce the predictive value of γ-H2AX foci decay ratio in patients undergoing pelvic radiotherapy;Radiation Oncology;2024-09-02

5. Stereotactic Magnetic Resonance–Guided Daily Adaptive Radiation Therapy for Localized Prostate Cancer: Acute and Late Patient-Reported Toxicity Outcomes;Advances in Radiation Oncology;2024-09